<i>Hepatology International</i>｜Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990—2021: a multi-model trend analysis and forecasting study

doi:10.12449/JCH2503.gwqkjpwzjj4

Volume 41 Issue 3

Mar. 2025

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2025 > 41(3): 567-567

PDF( 888 KB)

Hepatology International｜Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990—2021: a multi-model trend analysis and forecasting study

DOI: 10.12449/JCH2503.gwqkjpwzjj4

Published Date: 2025-03-25

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Hepatology｜Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2
[2]	Liver International｜MASLD, At-Risk MASH and increased liver stiffness are associated with young adulthood obesity without residual risk after losing obesity[J]. Journal of Clinical Hepatology, 2025, 41(2): 400-400. doi: 10.12449/JCH2502.gwqkjpwzjj4
[3]	Hepatology International｜Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data[J]. Journal of Clinical Hepatology, 2025, 41(3): 541-541. doi: 10.12449/JCH2503.gwqkjpwzjj2
[4]	Hepatology International｜Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials[J]. Journal of Clinical Hepatology, 2023, 39(1): 136-136. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj2
[5]	Hepatology International｜The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis[J]. Journal of Clinical Hepatology, 2023, 39(7): 1534-1534. doi: 10.3969/j.issn.1001-5256.2023.07.gwjpwzjj1
[6]	Hepatology International｜Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection[J]. Journal of Clinical Hepatology, 2023, 39(5): 1143-1143. doi: 10.3969/j.issn.1001-5256.2023.05.gwjpwzjj2
[7]	Hepatology International｜Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2023, 39(1): 21-21. doi: 10.3969/j.issn.1001-5256.2023.01.gwjpwzjj1
[8]	Hepatology International｜A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study[J]. Journal of Clinical Hepatology, 2023, 39(12): 2941-2941. doi: 10.3969/j.issn.1001-5256.2023.12.gwjpwzjj2
[9]	Hepatology International｜Establishment and validation of a prognostic model for hepatitis B virus-related acute-on-chronic liver failure patients with bacterial infection[J]. Journal of Clinical Hepatology, 2022, 38(4): 901-901. doi: 10.3969/j.issn.1001-5256.2022.04.gwjpwzjj3
[10]	Hepatology International｜Diabetes is associated with the poor short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2022, 38(2): 432-432. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj7
[11]	Hepatology International｜Effect of microbiota metabolites on the progression of chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2022, 38(3): 540-540. doi: 10.3969/j.issn.1001-5256.2022.3.gwjpwzjj1
[12]	Hepatology｜Gastrodin improves nonalcoholic steatohepatitis by activating the AMPK signaling pathway[J]. Journal of Clinical Hepatology, 2022, 38(2): 319-319. doi: 10.3969/j.issn.1001-5256.2022.02.gwjpwzjj2
[13]	Xinyu AN, Lingxi HU, Jie QIAO, Rongqi WANG, Yuemin NAN. Role of microRNAs in the development and progression of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(12): 2963-2966. doi: 10.3969/j.issn.1001-5256.2021.12.048
[15]	Zhang XiaXia, Xu YouQing. An excerpt of the recommendations of international liver transplantation society for management and treatment of nonalcoholic steatohepatitis (2018)[J]. Journal of Clinical Hepatology, 2019, 35(1): 64-66. doi: 10.3969/j.issn.1001-5256.2019.01.011
[16]	Zhu Peng, Xu Zong, Wang YuMing. World Gastroenterology Organisation global guidelines：nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2014, 30(9): 842-845. doi: 10.3969/j.issn.1001-5256.2014.09.002
[17]	Liu Jing, Shi JunPing. The immune pathogenesis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2012, 28(5): 339-342.
[20]	Dai Lin, Deng Bin, Li AiPing, Yu HongBo, Bai Cheng, Lu ShengMing. Experimental study on the pathogenesis of nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2004, 20(5): 285-286.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (56) PDF downloads(6)

Hepatology International｜Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990—2021: a multi-model trend analysis and forecasting study

DOI: 10.12449/JCH2503.gwqkjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Hepatology International｜Global, regional, and national burden of liver cancer due to non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, 1990—2021: a multi-model trend analysis and forecasting study

DOI: 10.12449/JCH2503.gwqkjpwzjj4

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content